Comparing Vimala massage and hydrotherapy for treating neonatal jaundice
Effect of Vimala Massage Versus Hydrotherapy on the Clinical Outcomes of Neonatal Hyperbilirubinemia
This study is testing whether Vimala massage or hydrotherapy can help newborns with jaundice get better compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 37 Weeks to 42 Weeks |
| Sex | All |
| Sponsor | Kafrelsheikh University Academic / other |
| Locations | 2 sites (Kafr Ash Shaykh, Kafr el-Sheikh and 1 other locations) |
| Trial ID | NCT06595368 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Vimala massage versus hydrotherapy in improving clinical outcomes for neonates with hyperbilirubinemia. Neonates will be randomly assigned to one of three groups: a control group receiving standard care, a group receiving Vimala massage three times daily, and a group receiving hydrotherapy twice daily. The study aims to assess the impact of these interventions on the management of neonatal jaundice. Data will be collected from the neonates' medical records and monitored throughout the intervention period.
Who should consider this trial
Good fit: Ideal candidates are full-term neonates aged 37-42 weeks with physiological jaundice and normal vital signs.
Not a fit: Patients with major congenital malformations, sepsis, or conditions affecting skin integrity may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide alternative non-invasive treatment options for managing neonatal jaundice.
How similar studies have performed: While there is limited data on the specific comparison of Vimala massage and hydrotherapy, similar non-invasive interventions have shown promise in managing neonatal jaundice.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: full-term neonates aged 37- 42 weeks of gestation with a birth weight of ≥1500 g and a five-minute Apgar score of seven or above. Furthermore, the newborn with physiological jaundice will be admitted for phototherapy from the first to the tenth day, and the infant's vital signs will remain normal Exclusion Criteria: * major congenital malformations, intestinal obstruction, congenital heart disease, sepsis, neonates with a disease that disrupts skin integrity (epidermolysis bullosa, ichthyosis, collodion baby).
Where this trial is running
Kafr Ash Shaykh, Kafr el-Sheikh and 1 other locations
- Kafrelsheikh University — Kafr Ash Shaykh, Kafr el-Sheikh, Egypt (Recruiting)
- Kafrelsheikh University — Kafr Ash Shaykh, Kafr el-Sheikh, Egypt (Recruiting)
Study contacts
- Study coordinator: Eman W abdelaal, Ass. Professor
- Email: eman_wardany_2014@nur.kfs.edu.eg
- Phone: 01065407334
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.